Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients' lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston's top workplaces for the past several years. We are seeking a motivated and patient-centric VP who is looking to have a broad and tangible impact on clinical development and commercialization of Kymera's industry-leading oral immunology/inflammation pipeline. Reporting into the CMO, this role will provide medical affairs leadership for our clinical immunology/inflammation pipeline, including driving development/launch for our STAT6 and TYK2 programs. This role will drive forward medical affairs strategy across multiple immunology/inflammation therapeutic areas including dermatology, respiratory, GI and rheumatology in close partnership with the clinical development and future commercial and market access teams.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Industry
Professional, Scientific, and Technical Services
Education Level
No Education Listed
Number of Employees
101-250 employees